Patents by Inventor Robert I. DeMars

Robert I. DeMars has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cytotoxic T lymphocyte epitopes of the major outer membrane protein of Chlamydia trachomatis
    Patent number: 6653461
    Abstract: Disclosed herein are 9 amino acid-long peptides from the major outer membrane protein (MOMP) of Chlamydia trachomatis serovar E. These peptides activate CD8+ cytotoxic T-lymphocytes in human infections that are potentially important for resolution of infection and protection against disease. Thus, the peptides, as well as DNA coding for them, are intended for use in vaccination of humans. Also, they are useful in connection with diagnostic tests.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: November 25, 2003
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Robert I. DeMars, Seon-Kyeong Kim
  • Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
    Publication number: 20010041788
    Abstract: Disclosed herein are 9 amino acid-long peptides from the major outer membrane protein (MOMP) of Chlamydia trachomatis serovar E. These peptides activate CD8+ cytotoxic T-lymphocytes in human infections that are potentially important for resolution of infection and protection against disease. Thus, the peptides, as well as DNA coding for them, are intended for use in vaccination of humans. Also, they are useful in connection with diagnostic tests.
    Type: Application
    Filed: December 28, 2000
    Publication date: November 15, 2001
    Inventors: Robert I. DeMars, Seon-Kyeong Kim
  • Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
    Patent number: 6225443
    Abstract: Disclosed herein are 9 amino acid-long peptides from the major outer membrane protein (MOMP) of Chlamydia trachomatis serovar E. These peptides activate CD8+ cytotoxic T-lymphocytes in human infections that are potentially important for resolution of infection and protection against disease. Thus, the peptides, as well as DNA coding for them, are intended for use in vaccination of humans. Also, they are useful in connection with diagnostic tests.
    Type: Grant
    Filed: April 17, 2000
    Date of Patent: May 1, 2001
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Robert I. DeMars, Seon-Kyeong Kim
  • Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
    Patent number: 6191259
    Abstract: Disclosed herein are short peptides from the major outer membrane protein of Chlamydia trachomatis serovar E. These fragments activate cytotoxic T-lymphocytes (CD8+). Thus, the fragments, as well as DNA coding for them, are intended for use in vaccination of humans. Also, they are useful in connection with diagnostic tests.
    Type: Grant
    Filed: May 19, 1999
    Date of Patent: February 20, 2001
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Robert I. DeMars, Seon-Kyeong Kim
  • Antigenic peptides of Chlamydia trachomatis
    Patent number: 6001372
    Abstract: Disclosed herein are short antigenic peptides of MOMP protein from Chlamydia trachomatis. They can be used to stimulate antigenic responses and to diagnose the presence of the bacteria.
    Type: Grant
    Filed: August 25, 1995
    Date of Patent: December 14, 1999
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Robert I. DeMars, Linette Ortiz